TAK1 modulators (X-Rx)

N/A

Report date: 2025/06/11 10:34:35
NME

Base Information

Drug NameTAK1 modulators (X-Rx)
Drug Alias NameTGFbeta -activated kinase 1 modulators (X-Rx)
ClassificationSmall molecules
Mechanisms of ActionTGF-β activated kinase-1 modulators
TargetsTGF-β activated kinase-1
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesX-Rx Discovery Inc
China Registration ClassN/A

Develop Information

Active CompaniesMercachem Holding BVX-Rx Discovery Inc
Inactive CompaniesN/A
Active IndicationsInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A